Congress is preparing to potentially work through the holidays until they can pass more coronavirus aid for the country. CBS News chief congressional correspondent Nancy Cordes, CBS News political correspondent Ed O’Keefe, and NPR White House correspondent Tamara Keith spoke to “Red and Blue” host Elaine Quijano about where negotiations stand, as well as the …
Continue reading “Coronavirus relief talks stalled in Congress as deadlines inch closer”
(Bloomberg) — Investors are winding up the week doing risk-off trades, with U.S. stimulus talks hung up and coronavirus developments weighing on sentiment. The dollar rose the most in almost two weeks. European stocks fell more than 1%, as Germany said the continent’s biggest economy had record virus cases and deaths. Sanofi dropped on news …
Continue reading “Stocks Slump, Dollar Rebounds Amid Risk-Off Mood: Markets Wrap”
A federal advisory panel on Thursday recommended the emergency use of Pfizer’s COVID-19 vaccine. The Food and Drug Administration is expected to approve the drug, kicking off a massive nationwide operation to get nearly 3 million doses of the vaccine to hospitals and drug stores across the country. “We’ve been working very closely with our …
Continue reading “FDA panel recommends Pfizer’s COVID-19 vaccine approval”
US Treasury Secretary Steven Mnuchin has said that senators from both parties are making progress on stimulus talks and more meetings are scheduled for later on Thursday. House Speaker Nancy Pelosi is set to speak later on. The S&P 500 Index has returned to positive territory after trading lower earlier in the day. Mnuchin has said …
Continue reading “A lot of progress made on stimulus – Mnuchin”
(Bloomberg) — Stocks fell on concern that prospects for a stimulus deal remain elusive amid the most-intense negotiations over a Covid-19 package since Election Day. The S&P 500 also dropped after data showed applications for U.S. unemployment benefits surged last week, topping most estimates. Technology shares continued to underperform, with Facebook Inc. slipping further as …
Continue reading “Stocks Drop, Bonds Rise Amid Stimulus Stalemate: Markets Wrap”
The coronavirus recession has been a relentless churn of high unemployment and economic uncertainty. The government stimulus that kept millions of Americans from falling into poverty earlier in the pandemic is long gone, and new aid is still a dot on the horizon after months of congressional inaction. Hunger is chronic, at levels not seen …
Continue reading “More Americans are shoplifting food as aid runs out during the pandemic”
https://youtu.be/5MNsM-ZhRS4 This video we will discuss and review a trial from ClinicalTrials.gov that have reported their results, but not published them. It is a randomized, double blinded, placebo control trial out of Bangladesh comparing treatment with Ivermectin and Doxycycline with standard care (tylenol, vitamin D, steroids as needed, oxygen as needed, etc) versus standard care …
‘Generic Drug Repurposing for COVID-19” The Israeli Perspective’: Tel Aviv University’s Spark program recently hosted a webinar titled “Generic Drug Repurposing for COVID-19: The Israeli Perspective.” In collaboration with the MedInsight Institute, presenters included Professor Alex Jadad, Faculty of Medicine and School of Public Health, University of Toronto, Canada; Moshe Rogosnitzky, Executive Director, MedInsight Research …
https://youtu.be/V4fEBK1inj4 Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019 Link Here: https://doi.org/10.1016/j.chest.2020.10.009 Original in-vitro study about Ivermectin https://www.ncbi.nlm.nih.gov/pmc/arti… A study from bangladesh found that Ivermectin + Doxyclyclin significantly reduces mortality and morbidity in COVID-19 patients. https://clinicaltrials.gov/ct2/show/s… A systemic review of the antiviral activity of Ivermectin https://www.nature.com/articles/s4142… https://journal.chestnet.org/article/… PDF …
Continue reading “Ivermectin Works For COVID-19 – LATEST STUDIES”
https://youtu.be/Tq8SXOBy-4w Pierre Kory, M.D., Associate Professor of Medicine at St. Luke’s Aurora Medical Center, delivers passionate testimony during the Senate Homeland Security and Governmental Affairs Committee hearing on “Early Outpatient Treatment: An Essential Part of a COVID-19 Solution, Part II.” Ivermectin has been trialled in treating the coronavirus SARS-CoV-2, which is the virus that causes …
Continue reading “Breakthrough Ivermectin used to treat COVID-19”